texas oncology more breakthroughs. more victories
I am a: Patient | Caregiver | Refering Physician
Request an Appointment

Clinical Publications and Presentations

PUBLICATION TITLE
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
PUBLICATION
The New England Journal of Medicine.
CITATION
N Engl J Med . 2022 Dec 13.
CLINICIANS
Jennifer R Brown, Barbara Eichhorst, Peter Hillmen, Wojciech Jurczak, Habte A Yimer, et al.
PUBLICATION TITLE
Zanubrutinib in Patients with Previously Treated B-cell Malignancies Intolerant of Previous Bruton Tyrosine Kinase Inhibitors in the USA: A Phase 2, Open-Label, Single-Arm Study
PUBLICATION
The Lancet Hematology
CITATION
Lancet Haematol . 2023 Jan;10(1):e35-e45
CLINICIANS
Mazyar Shadman, Ian W Flinn, Moshe Y Levy, Ryan F Porter, John M Burke, Habte A Yimer, et al.
PUBLICATION TITLE
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
PUBLICATION
Journal of Clinical Oncology
CLINICIANS
Peter Hillmen, MBChB, PhD1, Barbara Eichhorst, MD2, Jennifer R. Brown, MD, PhD, Habte A Yimer, M.D., et al.
PUBLICATION TITLE
Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone For Multiple Myeloma: Final Results of The LYRA Study
PUBLICATION
Leukemia & Lymphoma
CLINICIANS
Habte Yimer, Jason Melear, Edward Faber, Habte A Yimer, et al.
PUBLICATION TITLE
Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Advanced Stage Classic Hodgkin Lymphoma: Updated Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part B)
PUBLICATION
American Society of Hematology
CLINICIANS
Hun Lee, Ian W. Flinn, Jason Melear, Rod Ramchandren, Judah Friedman, John M. Burke, Yuliya Linhares, Tatyana Feldman, Habte Yimer, et al.
PUBLICATION TITLE
Genomic Characterization of Patients in A Phase 2 Study of Zanubrutinib in BTK Inhibitor–Intolerant Patients With Relapsed/Refractory B-Cell Malignancies
PUBLICATION
American Society of Hematology
CLINICIANS
Linlin Xu, Mazyar Shadman, Anusha Ponakala, Ian W. Flinn, Moshe Yair Levy, Ryan Porter, John M. Burke, Habte Yimer, et al.
PUBLICATION TITLE
Results from Outreach: A Phase 2 Study of Lisocabtagene Maraleucel (Liso-cel) Administered As Outpatient or Inpatient Treatment in The Community/Nonuniversity Setting in Patients (Pts) With Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL
PUBLICATION
American Society of Hematology
CLINICIANS
Yuliya Linhares, Cesar Freytes, Mohamad Cherry, Carlos Bachier, Michael Maris, Habte Yimer, et al.
PUBLICATION TITLE
Zanubrutinib Demonstrates Superior Progression-Free Survival (PFS) Compared With Ibrutinib For Treatment of R/R Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL): Results From Final Analysis of ALPINE Randomized Phase 3 Study
PUBLICATION
American Society of Hematology
CLINICIANS
Jennifer R. Brown, Barbara Eichhorst, Peter Hillmen, Nicole Lamanna, Susan M. O'Brien, Habte Yimer, et al.
PUBLICATION TITLE
Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010-2017
PUBLICATION
Breast Cancer Res Treat
CLINICIANS
Zhang H, Barner JC, Moczygemba LR, Rascati KL, Park C, Kodali D
PUBLICATION TITLE
Assessment of BMI and Venous Thromboembolism Rates in Patients on Standard Chemoprophylaxis Regimes After Undergoing Free Tissue Transfer to the Head and Neck
PUBLICATION
JAMA Otolaryngology - Head and Neck Surgery
CLINICIANS
Saadoun R, Bengur FB, Moroni EA, Surucu Y, Veit JA, Khan NI, Daniels K, Rothenberger SD, Kubik M, Solari MG, Sridharan S
Displaying results 31-40 (of 1812)
 <  1 2 3 4 5 6 7 8 9 10  > 

* Texas Oncology Clinicians